New ASIPP Interventional Pain Procedures Text

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Are there any chapters on SCS for FMS? 🙂

Oker, J "A Randomized Clinical Trial Using Peripheral Nerve vs Spinal Cord Stimulation for the Treatment of Chronic Fibromyalgia", J Alt Pain Med 2007, 3(2): P131-206
Fibromyalgia is a debilitating disease that some physician misinterpret as a psychological disease. In an earlier article, this author demonstrated fibromyalgia is a actually subset of short segment peripheral neuropathy that can only be identified through single fiber EMG performed on a specific series of 278 points spread throughout the body. For those patients that tolerated the EMG and had at least 93 positive points, one week after the bleeding stopped they were enrolled in a randomized study in which half received spinal cord stimulation or peripheral nerve stimulation both via percutaneous lead placement. The spinal cord stimulation 8 electrode percutaneous lead was placed in the usual fashion at L2/3 and advanced in the midline until the tip lie at the level of approximately the mid-medulla. A loud pop was heard as a sign of confirmation once the lead was advanced rostral to the C1 level. Those receiving peripheral nerve stimulation had quadrupolar electrode leads placed percutaneously into the most tender 31 points. Each tender point received one lead. Due to technical considerations that were unanticipated, the trial stimulator battery voltages were not high enough to power the peripheral lead arrays after they were connected together using a series of Radio Shack spinal cord stimulator lead signal splitters (cat. no. 18871). A total of 145 volts were calculated to be required to power the peripheral array, therefore 120 VAC was substituted for the trial stimulator battery. Curiously stimulation of the medullary lead required only 15 microamps at 1.5 volts. The results in the 1/4 of the patients that completed the study without electrical burns or new neurological deficits, were encouraging. There was a 50% relief in each group of those completing the study. Therefore it may be concluded peripheral nerve stimulation with 31leads (124 electrodes) is a viable treatment for a selected set of fibromyalgia patients. Although the results in the survivors of the medullary stimulation limb were encouraging, the major new neurological deficits may be viewed by some as a detriment, and therefore the technique cannot be recommended at this time. It is suggested that now the human trials have been completed, that animal models be used to explain the mechanism of action and further examine the safety profile.
 
Are there any chapters on SCS for FMS? 🙂

Oker, J "A Randomized Clinical Trial Using Peripheral Nerve vs Spinal Cord Stimulation for the Treatment of Chronic Fibromyalgia", J Alt Pain Med 2007, 3(2): P131-206
Fibromyalgia is a debilitating disease that some physician misinterpret as a psychological disease. In an earlier article, this author demonstrated fibromyalgia is a actually subset of short segment peripheral neuropathy that can only be identified through single fiber EMG performed on a specific series of 278 points spread throughout the body. For those patients that tolerated the EMG and had at least 93 positive points, one week after the bleeding stopped they were enrolled in a randomized study in which half received spinal cord stimulation or peripheral nerve stimulation both via percutaneous lead placement. The spinal cord stimulation 8 electrode percutaneous lead was placed in the usual fashion at L2/3 and advanced in the midline until the tip lie at the level of approximately the mid-medulla. A loud pop was heard as a sign of confirmation once the lead was advanced rostral to the C1 level. Those receiving peripheral nerve stimulation had quadrupolar electrode leads placed percutaneously into the most tender 31 points. Each tender point received one lead. Due to technical considerations that were unanticipated, the trial stimulator battery voltages were not high enough to power the peripheral lead arrays after they were connected together using a series of Radio Shack spinal cord stimulator lead signal splitters (cat. no. 18871). A total of 145 volts were calculated to be required to power the peripheral array, therefore 120 VAC was substituted for the trial stimulator battery. Curiously stimulation of the medullary lead required only 15 microamps at 1.5 volts. The results in the 1/4 of the patients that completed the study without electrical burns or new neurological deficits, were encouraging. There was a 50% relief in each group of those completing the study. Therefore it may be concluded peripheral nerve stimulation with 31leads (124 electrodes) is a viable treatment for a selected set of fibromyalgia patients. Although the results in the survivors of the medullary stimulation limb were encouraging, the major new neurological deficits may be viewed by some as a detriment, and therefore the technique cannot be recommended at this time. It is suggested that now the human trials have been completed, that animal models be used to explain the mechanism of action and further examine the safety profile.

Hysterically funny, but Algos, you have way too much spare time on your hands!
 
http://www.asipp.org/ITCSP-orderform-1.pdf.pdf

It's not coming out until this summer, but any early opinions on this book?

I'd like to get a general idea before forking over $400-500 for it.

ASIPP is a great organization for what they do - lobby to get us paid fairly for the work we do. When they start venturing into the realm of guidelines, textbooks, certification, etc, they are poaching the domain of organizations dedicated to the science of what we do.

This book looks a lot like the pain physician journal - you know the one - Dr. M writes an article, Dr. S reviews it, then Dr. S writes an article, Dr. M reviews it. Now mind you, I haven't read of page of it, but that is my inclination.

I will leave it to Algos for his requisite anti-ASIPP rant, but suffice it to say, ASIPP ought to be the lobbying arm of the pain world. Duplicating the efforts of other groups just makes them look like they are overstepping their legitimate mandate.
 
The field definitely needs a "Big Tent" mentality to leverage its resources effectively and be taken seriously by health care stakeholders. AAPM, ISIS, and ASIPP each does some things well. Despite what each individual group espouses and believes, their philosophical and practical similarities far out number their differences. I think PASSOR and ASRA are probably the "bookends" on the interventional pain society continuum.

I propose that the groups do a Lollapalooza of Pain Medicine one year and hold joint conferences and annual conventions. That'd be cool...
 
The field definitely needs a "Big Tent" mentality to leverage its resources effectively and be taken seriously by health care stakeholders. AAPM, ISIS, and ASIPP each does some things well. Despite what each individual group espouses and believes, their philosophical and practical similarities far out number their differences. I think PASSOR and ASRA are probably the "bookends" on the interventional pain society continuum.

I propose that the groups do a Lollapalooza of Pain Medicine one year and hold joint conferences and annual conventions. That'd be cool...

Dr. M is the featured speaker at ISIS this July
 
ASIPP ought to be the lobbying arm of the pain world. Duplicating the efforts of other groups just make them look like they are overstepping their legitimate mandate.

Mandated by whom?

But, you are right, this looks like their answer to the ISIS Guidelines.


At 5 times the cost.
 
ASIPP is a great organization for what they do - lobby to get us paid fairly for the work we do. When they start venturing into the realm of guidelines, textbooks, certification, etc, they are poaching the domain of organizations dedicated to the science of what we do.

This book looks a lot like the pain physician journal - you know the one - Dr. M writes an article, Dr. S reviews it, then Dr. S writes an article, Dr. M reviews it. Now mind you, I haven't read of page of it, but that is my inclination.

I will leave it to Algos for his requisite anti-ASIPP rant, but suffice it to say, ASIPP ought to be the lobbying arm of the pain world. Duplicating the efforts of other groups just make them look like they are overstepping their legitimate mandate.

Can you clarify what articles trouble you and can you clarify why you are attacking the integrity of the Pain Physician peer review process?

And furthermore what is exactly scientific about ISIS?

A closed anatomic model of spine pain defined by so and so nerve going to so and so structure causing so and so pain is obsolete and dated.

At a minimum, ISIS should start incorporating peer reviewed articles on the neurobiology of pain, pharmacology of local anesthetics, regional anesthesia, and of course the vast Japanese literature, e.g. Aoki, Nakamura...before they take the high road on science.

A lot has happened to pain medicine since Bogduk dissected out spinal nerves in monkeys, 33 years ago....I think spine pain is a little more complicated than dripping 0.5 cc of LA on a tiny 5mm nerve and that demonstrating a 50% improvement in the SF-36 and return to work is a bit much to ask of a 3.5 in 25 guage needle.

Dr. Manchikanti has published the largest body of peer reviewed literature on facet injections and Dr. Singh has pioneered a number of intradiscal treatments. At a minimum, whatever you believe, they were courageous enough to publish their patient data from a private practice environment and demonstrate that it could be safely done outside the hands of Donlin M. Long.

Arguably, if it weren't for some of their publications, we would only be doing blocks and RF in the context of an IRB approved, independently funded clinical trial on properly selected patients with whiplash in an academic medical center.

Now you have literature that you can show the med exec committee of a hospital, your local med mal insurance carrier-as to why RFTC is not a neurosurgical procedure, and your managed care companies.

Some recent reviews on RFTC have criticized that RFTC is not effective. At least the ASIPP Guidelines still enable patients access to these treatments and act as a countermeasure to systematic reviews that have a microscopic approach to interpreting efficacy.

And for those pmr folks out there, Dr. Manchikanti changed the name to ASIPP from the American Society of Pain Management Anesthesiologists in the 1998-1999, because he recognized the importance of physiatrists.
With new information, ASIPP has evolved. All societies can learn from their mistakes, some change and some cling to the past. ASIPP has changed.

ASIPP recognizes the problems facing pain management and patient access to care and have been true to their mission statement. It is now trying its best to preserve the credibility of interventional pain physicians...by administering various certifications and review courses.

Quite simply, ASIPP conducted a SWOT (Strengths, Weakness, Opportunities, and Threats) analysis and understands better than any society out there...what it takes to ensure interventional pain survives.

Imagine a day wherein the managed care companies demand that you be board certified in interventional pain medicine, before you are allowed to perform an interventional pain procedure?

If you disagree with ASIPP, fine... but conduct your own SWOT analysis from a practice and scientific standpoint.

e.g. Conduct a SWOT analysis from a scientific standpoint about whether ISIS's views about spine pain can survive another 20 years.
 
Some recent reviews on RFTC have criticized that RFTC is not effective. At least the ASIPP Guidelines still enable patients access to these treatments and act as a countermeasure to systematic reviews that have a microscopic approach to interpreting efficacy.

I agree.

I've used the ASIPP Guidelines to get many procedures authorized.
 
ASIPP has made contributions to the political aspects of pain medicine that are significant both numerically and with respect to the impact. Their contributors to their journal largely are respected in their field, and publish guidelines that have been useful to us, whether we directly use them or whether they are reviewed by medical directors of insurance. ASIPP as an organization has some leaders in the field of pain medicine, but more importantly its membership includes a very large cross section of those engaged in the active practice of pain medicine. All of us have free access to the journal and its contents.
In spite of my prior misgivings about the development of the organizational leadership, the scientific publications, and the political will being focused extensively and controlled either directly or indirectly by one individual, ASIPP has blossomed into a beautiful example of cooperative efforts that transcends its weaknesses, some of which remain. ASIPP is now larger than one person and its board does not walk in lockstep with its leader on all issues. This independence of the board will be the most important aspect of the validation of the organization as an entity representing the needs of all pain physicians. The contributions of a single individual jumpstarted an entire movement, and we appreciate those contributions for what they were. Now it is time for those of us in the ranks to contribute both with scientific publications and with political muscle to support ASIPP and assure its continued broad contributions to pain medicine as a whole. ISIS and ASIPP can coexist side by side, both having had significant past impact, and both have a bright future in the movement forward beyond the relatively primitive level of advancement in which we currently operate as practitioners compared to that future. All guidelines, those of ISIS and ASIPP are useful to pain medicine in their own way. ISIS guidelines represent a consensus of experts in the field for the safest and most effective manner for conduct of procedures. ASIPP has exhaustive reviews of efficacy of procedures. Both are useful to the pain physician.
 
Now you have literature that you can show the med exec committee of a hospital, your local med mal insurance carrier-as to why RFTC is not a neurosurgical procedure, and your managed care companies.

That is exactly the role ASIPP should play, and if that WERE all they were attempting to accomplish, that would be terrific.

At a minimum, ISIS should start incorporating peer reviewed articles on the neurobiology of pain, pharmacology of local anesthetics, regional anesthesia, and of course the vast Japanese literature, e.g. Aoki, Nakamura...before they take the high road on science.

There is a reason ISIS does not have the word "pain" in the name of the organization. They have partnered with AAPM exactly for that reason.

ASIPP has changed...

The recent ravings and rants between Dr. M and the ISIS board (including esteemed members of our Pain Rounds colleagues) might speak otherwise.

ASIPP recognizes the problems facing pain management and patient access to care and have been true to their mission statement. It is now trying its best to preserve the credibility of interventional pain physicians...by administering various certifications and review courses.

ASIPPs mission is to get us paid, nothing more, and nothing less. Couching that mission in scientific platitudes, or in the subterfuge of calling what they do real anything other than tactics, strategies, and political posturing, is nonsense. ASIPP certification and review courses fill their coffers for the political fights ahead - but the quality of their publications, and their courses in no way measure up to those we already acknowledge as the gold standards.
 
The field definitely needs a "Big Tent" mentality to leverage its resources effectively and be taken seriously by health care stakeholders. AAPM, ISIS, and ASIPP each does some things well. Despite what each individual group espouses and believes, their philosophical and practical similarities far out number their differences. I think PASSOR and ASRA are probably the "bookends" on the interventional pain society continuum.

I propose that the groups do a Lollapalooza of Pain Medicine one year and hold joint conferences and annual conventions. That'd be cool...


Lollapalooza. That sure brings back memories.

Summer '92-Pearl Jam, Chili Peppers, Ministry, House of Pain, Ice-Cube 👍

Any Gen-Xers out there?

Anyway, I'm not sure you can spread the pain umbrella that wide.

A joint conference would work with pain organizations with modest philosophical differences (AAPM, ASIPP, APS), but NASS is predominantly made up of surgeons, PASSOR is more of a sports and occ med organization and ASRA (at least in it's name) is 50% regional anesthesia.

The above listed organizations really represent different specialties with the common ground being the procedures.
 
That is exactly the role ASIPP should play, and if that WERE all they were attempting to accomplish, that would be terrific.



There is a reason ISIS does not have the word "pain" in the name of the organization. They have partnered with AAPM exactly for that reason.



The recent ravings and rants between Dr. M and the ISIS board (including esteemed members of our Pain Rounds colleagues) might speak otherwise.



ASIPPs mission is to get us paid, nothing more, and nothing less. Couching that mission in scientific platitudes, or in the subterfuge of calling what they do real anything other than tactics, strategies, and political posturing, is nonsense. ASIPP certification and review courses fill their coffers for the political fights ahead - but the quality of their publications, and their courses in no way measure up to those we already acknowledge as the gold standards.

come up with a better defense for your positions.
 
come up with a better defense for your positions.

1) My defenses are fine, reasonable, and justified. Just because you can't respond to them with anything other that vitriol doesn't dispute their adequacy

2) You might want to consider seeking professional counseling for your hostility.
 
I will have to come down on the side of those who criticize the quality of what's published in PP. I used to do peer review for some journals back in my academic incarnation and much of what I see in PP (and most pain journals) would never pass muster in established non-pain journals.

To a certain extent this is due to the vagaries of evaluating pain. There is no test for it so we have no marker other than highly subjective self-reporting. It's not like measuring blood sugars on two different drugs.

However, even allowing for all that, the actual methodology and analysis should be well-designed, and the conclusions should follow from the results. Instead many pain journal articles are painful to read and it is unclear exactly what was done and what came out of it. I have spent quite a bit of time poring over an article trying to figure out what they did, and sometimes I just had to give up.

I can tell you from my experience as a peer reviewer that the "old boy" network definitely operates in the publishing world. Another problem is that there are too many journals chasing too few quality papers, and you have fill those pages with something. So for various reasons a paper that is garbage will be massaged and rewritten and buffed as much as possible and then published.

The problem, however, is that no matter how much you dress it up, you can't hide what it's made of ("fecum non simonatum").
 
Top